MAPT and Cognitive impairment: To provide a rigorous comparison between patients with mild cognitive impairment due to Alzheimer’s disease (MCI-AD) and healthy elderly, as well as to assess the value of electroencephalography (EEG) in terms of early diagnosis, we conducted a neutral image recognition memory task involving individuals with positive biomarkers including β amyloid deposition, pathologic tau or neurodegeneration.